Codexis (CDXS) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Codexis Reports 2017 Fourth Quarter and Full Year Financial Results
March 8, 2018 4:05 PM ESTÂ 2017 revenues of $50 million include a 74% increase in product salesIntroduces 2018 financial guidance
Conference call begins at 4:30 pm Eastern time todayAccompanying slide presentation available on Investor section of company websiteÂ
REDWOOD CITY, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces financial results for the three and 12 months ended December 31, 2017, provides a business update and introduces 2018 financial guidance.
We closed out an exceptional year with fourth quarter revenues exceeding $21 million, more than double third quarter revenues, said... More
